New Strategies for Cancer Gene Therapy: Progress and Opportunities

Loading...
Thumbnail Image
File version
Author(s)
Cao, Siyu
Cripps, Allan
Wei, Ming Q
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Siyu Cao, Allan Cripps, Ming Q Wei
Date
2010
Size
994640 bytes
File type(s)
application/pdf
Location
License
Abstract

New Strategies for Cancer Gene Therapy: Progresses and Opportunities. Cao S, Cripps A, Wei MQ. Griffith Institute for Health and Medical Research, School of Medical Science, Griffith University, Gold Coast campus, Southport, Qld 4222, Australia. 1. To date, cancer persists as one of the most devastating diseases worldwide. Problems including metastasis and tumour resistance to chemotherapy and radiotherapy have seriously limited therapeutic effects of existing clinical treatments. 2. To address these problems, cancer gene therapy has been developing over the last two decades, specifically designed to deliver therapeutic genes to treat cancers using vector systems. So far, a number of genes and delivery vehicles have been evaluated and significant progresses made with several gene therapy modalities in clinical trials. However, the lack of an ideal gene delivery system remains a major obstacle for its successful translation to the clinics. 3. Recent understanding of hypoxic and necrotic regions within solid tumours and rapid development of recombinant DNA technology have reignited the idea of using anaerobic bacteria as novel gene delivery systems. These bacterial vectors have unique advantages over other delivery systems and are likely to become the vector of choice for cancer gene therapy in the near future. 4. Meanwhile, complicated tumour patho-physiology and associated metastasis make it hard to rely on a single therapeutic modality for complete tumour eradication. Therefore, the combination of cancer gene therapy with other conventional treatments has become paramount. 5. This review will introduce important cancer gene therapy strategies and major vector systems that have been studied so far with an emphasis on bacteria mediated cancer gene therapy. Additionally, exemplary combined therapies will also be briefly reviewed. PMID: 19671071 [PubMed - as supplied by publisher]

Journal Title
Clinical and Experimental Pharmacology and Physiology
Conference Title
Book Title
Edition
Volume
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
© 2010 The Authors and Blackwell Publishing Asia Pty Ltd. This is the author-manuscript version of this paper. Reproduced in accordance with the copyright policy of the publisher. The definitive version is available at http://onlinelibrary.wiley.com/
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Zoology
Cancer therapy (excl. chemotherapy and radiation therapy)
Pharmacology and pharmaceutical sciences
Medical physiology
Clinical sciences
Persistent link to this record
Citation
Collections